Search Within

Tahir N Sheikh

Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. GSK Faculty (2)
  4. Head and Neck Service (2)
  5. Advanced Practice Providers (1)
  6. Biostatistics Service (1)

More Groups

People
  1. Gary Schwartz (9)
  2. Archie Tse (6)
  3. Jayasree Nair (3)
  4. Alan Ho (2)
  5. Samuel Mc Neely (2)
  6. Aimee Crago (1)

More People

Years
  1. 2023 (1)
  2. 2013 (2)
  3. 2011 (1)
  4. 2010 (1)
  5. 2009 (2)
  6. 2008 (1)

More Years

Publications
  1. Cancer Research (3)
  2. Clinical Cancer Research (2)
  3. Anticancer Research (1)
  4. Cell Cycle (1)
  5. Journal of Clinical Oncology (1)
  6. Molecular Pharmacology (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Association for the Advancement of Science (1)
  3. American Society of Clinical Oncology (1)
  4. International Institute of Anticancer Research (1)
  5. Taylor & Francis Inc. (1)
  6. The American Society for Pharmacology and Experimental Therapeutics (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma
    Meeting Abstract

    Lacuna, K. P.; Lee, S. M.; Ge, L.; Druta, M.; Conley, A. P.; Keohan, M. L.; Agulnik, M.; Burgess, M. A.; Chalmers, A. W.; D'Amato, G. Z.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets
    Journal Article

    Miller, M. L.; Molinelli, E. J.; Nair, J. S.; Sheikh, T.; Samy, R.; Jing, X.; He, Q.; Korkut, A.; Crago, A. M.; Singer, S.; more...
    Science Signaling (2013)

    Fulltext@MSK | Save
  • PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor
    Journal Article

    Nair, J. S.; Sheikh, T.; Ho, A. L.; Schwartz, G. K.
    Anticancer Research (2013)

    Fulltext@MSK | Save
  • PTEN is a critical determinant in sensitizing cells to gamma-secretase inhibitors
    Meeting Abstract

    Nair, J. S.; Sheikh, T. N.; Li, Y. M.; Schwartz, G. K.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase
    Journal Article

    McNeely, S.; Conti, C.; Sheikh, T.; Patel, H.; Zabludoff, S.; Pommier, Y.; Schwartz, G.; Tse, A.
    Cell Cycle (2010)

    Fulltext@MSK | Save
  • Chk1 inhibition after replicative stress causes a double strand break response mediated primarily by DNA-dependent protein kinase
    Meeting Abstract

    McNeely, S. C.; Conti, C.; Sheikh, T.; Pommier, Y.; Schwartz, G. K.; Tse, A. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • 90-kDa heat shock protein inhibition abrogates the topoisomerase i poison-induced G(2)/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1
    Journal Article

    Tse, A. N.; Sheikh, T. N.; Ho, A.; Chou, T. C.; Schwartz, G. K.
    Molecular Pharmacology (2009)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
    Journal Article

    Tse, A. N.; Klimstra, D. S.; Gonen, M.; Shah, M.; Sheikh, T.; Sikorski, R.; Carvajal, R.; Mui, J.; Tipian, C.; O'reilly, E.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo
    Journal Article

    Tse, A. N.; Rendahl, K. G.; Sheikh, T.; Cheema, H.; Aardalen, K.; Embry, M.; Ma, S.; Moler, E. J.; Zhi, J. N.; De Menezes, D. E. L.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • The Hsp90 inhibitor, 17-Allylamino-17-Demethoxygeldanamycin (17AAG) abrogates the G(2)/M DNA damage checkpoint and induces apoptosis selectively in p53-defective colon cancer cells by down-regulating both Chk1 and Wee1
    Meeting Abstract

    Tse, A. N.; Sheikh, T. N.; Schwartz, G. K.
    Cancer Research (2005)

    Fulltext@MSK | Save